
    
      PRIMARY OBJECTIVES:

      I. To assess feasibility and acceptability of the iConquerFear program for patients with
      renal cell carcinoma (RCC).

      II. To assess preliminary effects of the program on Fear of Cancer Recurrence-7 item scale
      (FCR-7), Patient-Reported Outcomes Measurement Information System (PROMIS)-anxiety,
      PROMIS-depression, and Functional Assessment of Chronic Illness Therapy-General (FACT-G).

      III. Explore differences in feasibility and efficacy of iConquerFear by sociodemographic or
      clinical factors.

      OUTLINE:

      Patients complete 5 sessions of iConquerFear program online over 5 weeks. Patients also
      complete questionnaires at baseline, after the intervention, and 2 months later.
    
  